Stocktoria

Exousia Bio, Inc. LMMY

OTC · stock · Services-Educational Services · website · IPO 2024-04-30

Exousia Bio, Inc. statistics & valuation

P / B1.5×

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
15.90% -93.40% 202320242025202520252026
Operating margin (%)
202320242025202520252026
Return on equity (%)
202320242025202520252026
Shares outstanding
7.8M 7.8M 7.8M 7.8M 70.0M 70.0M 202320242025202520252026
Net debt ($)
202320242025202520252026
Share buybacks ($)
202320242025202520252026
Return on assets (%)
-152.30% -94.00% 202320242025202520252026
Free cash flow margin (%)
202320242025202520252026
Debt / equity (×)
202320242025202520252026
EPS ($)
$0.00 $0.00 $0.00 202320242025202520252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2025FY2025FY2024FY2023
Gross margin———-93.4%15.9%—
Net margin———1370.5%-224.4%—
Return on assets————-94.0%-152.3%
Return on equity————47.0%194.0%
Current ratio0.000.000.00—0.912.18

Computed from company filings · US · as of 2026-02-28. Facts plus Stocktoria's own computed scores — not investment advice.